These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16498501)

  • 21. Object recognition memory and cholinergic parameters in mice expressing human presenilin 1 transgenes.
    Vaucher E; Fluit P; Chishti MA; Westaway D; Mount HT; Kar S
    Exp Neurol; 2002 Jun; 175(2):398-406. PubMed ID: 12061869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging.
    Nakagawa Y; Nakamura M; McIntosh TK; Rodriguez A; Berlin JA; Smith DH; Saatman KE; Raghupathi R; Clemens J; Saido TC; Schmidt ML; Lee VM; Trojanowski JQ
    J Comp Neurol; 1999 Aug; 411(3):390-8. PubMed ID: 10413774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices.
    Kar S; Seto D; Gaudreau P; Quirion R
    J Neurosci; 1996 Feb; 16(3):1034-40. PubMed ID: 8558231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology.
    Klingner M; Apelt J; Kumar A; Sorger D; Sabri O; Steinbach J; Scheunemann M; Schliebs R
    Int J Dev Neurosci; 2003 Nov; 21(7):357-69. PubMed ID: 14599482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.
    Simón AM; de Maturana RL; Ricobaraza A; Escribano L; Schiapparelli L; Cuadrado-Tejedor M; Pérez-Mediavilla A; Avila J; Del Río J; Frechilla D
    J Alzheimers Dis; 2009; 17(4):773-86. PubMed ID: 19542617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The acetylcholine innervation of cerebral cortex: new data on its normal development and its fate in the hAPP(SW,IND) mouse model of Alzheimer's disease.
    Descarries L; Aznavour N; Hamel E
    J Neural Transm (Vienna); 2005 Jan; 112(1):149-62. PubMed ID: 15599613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.
    Volianskis A; Køstner R; Mølgaard M; Hass S; Jensen MS
    Neurobiol Aging; 2010 Jul; 31(7):1173-87. PubMed ID: 18790549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation.
    Nilsson LN; Arendash GW; Leighty RE; Costa DA; Low MA; Garcia MF; Cracciolo JR; Rojiani A; Wu X; Bales KR; Paul SM; Potter H
    Neurobiol Aging; 2004 Oct; 25(9):1153-67. PubMed ID: 15312961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early increases in soluble amyloid-β levels coincide with cholinergic degeneration in 3xTg-AD mice.
    Girão da Cruz MT; Jordão J; Dasilva KA; Ayala-Grosso CA; Ypsilanti A; Weng YQ; Laferla FM; McLaurin J; Aubert I
    J Alzheimers Dis; 2012; 32(2):267-72. PubMed ID: 22776965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.
    Bard F; Cannon C; Barbour R; Burke RL; Games D; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Lieberburg I; Motter R; Nguyen M; Soriano F; Vasquez N; Weiss K; Welch B; Seubert P; Schenk D; Yednock T
    Nat Med; 2000 Aug; 6(8):916-9. PubMed ID: 10932230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation.
    Liu HL; Zhao G; Cai K; Zhao HH; Shi LD
    Behav Brain Res; 2011 Apr; 218(2):308-14. PubMed ID: 21192984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
    Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
    Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of extracts of Ginseng and Ginkgo biloba on hippocampal acetylcholine and monoamines in PDAP-pV717I transgenic mice].
    Cong WH; Liu JX; Xu L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Sep; 27(9):810-3. PubMed ID: 17969894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired hippocampal and thalamic acetylcholine release in P301L tau-transgenic mice.
    Stein C; Koch K; Hopfeld J; Lobentanzer S; Lau H; Klein J
    Brain Res Bull; 2019 Oct; 152():134-142. PubMed ID: 31323279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and reduction of AD-type pathology in PDAPP mice immunized with A beta 1-42.
    Games D; Bard F; Grajeda H; Guido T; Khan K; Soriano F; Vasquez N; Wehner N; Johnson-Wood K; Yednock T; Seubert P; Schenk D
    Ann N Y Acad Sci; 2000; 920():274-84. PubMed ID: 11193164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reappraising neurotransmitter-based strategies.
    Möller HJ
    Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S53-9. PubMed ID: 10332935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.